CLX vs ORMP
The Clorox Company (CLX) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. Revenue was up 0.2% from 2024-06-30 to 2025-06-30. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the CLX and ORMP stock pages for the full models.
Not investment advice.